SBC Medical Group
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +53.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 0.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 10.1x | Better than 80% |
| Forward P/E | 14.1x | Better than 59% |
| Price / Sales | 4.3x | Better than 27% |
| P/E vs own 5-yr range | 87th pctl | Better than 18% |
Growth B+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -0.1% | Better than 24% |
| Net income CAGR (3Y) | 100.6% | Better than 95% |
Profitability A+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 73.3% | Better than 85% |
| Operating margin | 38.9% | Better than 95% |
| Net margin | 29.4% | Better than 89% |
| Return on equity | 23.0% | Better than 82% |
| Return on invested capital | 20.1% | Better than 90% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 29.3% | Better than 98% |
| 6-month return | 68.4% | Better than 97% |
| 12-month return (ex latest month) | 59.5% | Better than 87% |
| Distance below 52-week high | 30.0% | Better than 43% |
Financial Health B+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.8x | Better than 79% |
| Debt to assets | 13.6% | Better than 64% |
| Interest coverage | 512.0x | Better than 97% |
| Free cash flow / net income | 43.1% | Better than 12% |
Analyst View N/A
What the Street thinks: share of Buy ratings and upside to the average target.
Not enough data to grade this factor.
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 5.60
- Open
- 5.50
- Day range
- 5.03 - 5.53
- Avg price
- 5.22
- Volume
- 377.69K
- Turnover
- 1.97M
- Turnover ratei
- 2.09%
- Volume ratioi
- 0.41
- Amplitudei
- 8.96%
- 52-week rangei
- 2.78 - 7.39
Valuation
- P/Ei
- 10.34
- P/E (TTM)i
- 10.14
- P/Bi
- 1.85
- EPSi
- 0.50
- Book value / shi
- 2.79
- Net profit
- 51.42M
- Net assets
- 286.84M
Share structure
- Market cap
- 531.72M
- Float capi
- 93.60M
- Shares out
- 102.85M
- Float sharesi
- 18.10M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
30.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-153.57K net over the window
Short interest
- Shares short
- 840.71K
- % of floati
- 0.82%
- Days to coveri
- 4.57
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of SBC Medical Group (SBC)?
SBC Medical Group last traded at 5.17. This page shows a periodic quote snapshot. Check the displayed quote time.
What is SBC Medical Group's market cap?
About 531.72M.
What is the P/E ratio of SBC Medical Group?
The trailing twelve-month P/E is 10.14, below its own 5-year average of 13.12 — toward the top of its historical range (87.11% percentile). See the Valuation tab for the full history.
Does SBC Medical Group pay a dividend?
SBC Medical Group does not currently pay a regular dividend.
Is SBC Medical Group a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 8.50, which implies 64.4% upside from the current price. This is not investment advice.
What is SBC Medical Group's StockVane Quant Rating?
The StockVane Momentum strategy currently rates SBC Medical Group a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:39 · For reference only, not investment advice and not tailored to your situation.
SBC Medical Group discussion 0 comments